A Degarelix Trial in Patients With Prostate Cancer
Public ClinicalTrials.gov record NCT01242748. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multi-Centre, Extension Trial, Evaluating the Long-Term Progression-Free Survival of Degarelix or Goserelin Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Deprivation Therapy
Study identification
- NCT ID
- NCT01242748
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Enrollment
- 288 participants
Conditions and interventions
Conditions
Interventions
- Degarelix Drug
- Goserelin acetate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2010
- Primary completion
- Nov 30, 2011
- Completion
- Dec 31, 2011
- Last update posted
- Jun 2, 2015
2010 – 2012
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Colorado School of Medicine | Aurora | Colorado | — | — |
| The Urology Center of Colorado | Denver | Colorado | — | — |
| Urology Associates of Dover, PA | Dover | Delaware | — | — |
| South Florida Medical Research | Aventura | Florida | — | — |
| Urology Group of New Mexico, PC | Albuquerque | New Mexico | — | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | — | — |
| Urology San Antonio Research, Pa | San Antonio | Texas | — | — |
| Seattle Urology Research Center | Burien | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01242748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2015 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01242748 live on ClinicalTrials.gov.